MA34392B1 - Pyrimidines en tant qu'agents antiviraux - Google Patents

Pyrimidines en tant qu'agents antiviraux

Info

Publication number
MA34392B1
MA34392B1 MA35586A MA35586A MA34392B1 MA 34392 B1 MA34392 B1 MA 34392B1 MA 35586 A MA35586 A MA 35586A MA 35586 A MA35586 A MA 35586A MA 34392 B1 MA34392 B1 MA 34392B1
Authority
MA
Morocco
Prior art keywords
compounds
pyrimidines
antiviral agents
compositions
formula
Prior art date
Application number
MA35586A
Other languages
English (en)
Inventor
Kerim Babaoglu
Constantine G Boojamra
Eugene J Eisenberg
Hon Chung Hui
Richard L Mackman
Jay P Parrish
Michael Sangi
Oliver L Saunders
Dustin Siegel
David Sperandio
Hai Yang
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MA34392B1 publication Critical patent/MA34392B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des composés de formule I ou de formule II : (I), (II) ou un sel ou un ester pharmaceutiquement acceptables de ceux-ci, tels que décrits dans le présent document. Les composés et compositions de ceux-ci sont utiles pour le traitement d'infections par les virus Pneumovirinae. Les composés, compositions et procédés décrits sont particulièrement utiles dans le traitement d'infections par le virus respiratoire syncytial humain.
MA35586A 2010-06-24 2011-06-23 Pyrimidines en tant qu'agents antiviraux MA34392B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35812210P 2010-06-24 2010-06-24
PCT/US2011/041688 WO2011163518A1 (fr) 2010-06-24 2011-06-23 Pyrazolo[1,5-a]pyrimidines en tant qu'agents antiviraux

Publications (1)

Publication Number Publication Date
MA34392B1 true MA34392B1 (fr) 2013-07-03

Family

ID=44509853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35586A MA34392B1 (fr) 2010-06-24 2011-06-23 Pyrimidines en tant qu'agents antiviraux

Country Status (38)

Country Link
US (7) US8486938B2 (fr)
EP (2) EP2585467B1 (fr)
JP (4) JP5878171B2 (fr)
KR (1) KR101970837B1 (fr)
CN (2) CN102958933B (fr)
AP (1) AP3417A (fr)
AR (1) AR082275A1 (fr)
AU (1) AU2011270798B2 (fr)
BR (1) BR112012033117A2 (fr)
CA (1) CA2800834C (fr)
CL (1) CL2012003632A1 (fr)
CO (1) CO6640297A2 (fr)
CR (1) CR20130023A (fr)
CY (1) CY1118239T1 (fr)
DK (1) DK2585467T3 (fr)
EA (2) EA201591390A1 (fr)
EC (2) ECSP13012400A (fr)
ES (2) ES2700542T3 (fr)
HK (3) HK1223934A1 (fr)
HR (1) HRP20160431T1 (fr)
HU (1) HUE029174T2 (fr)
IL (2) IL223253B (fr)
MA (1) MA34392B1 (fr)
ME (1) ME02397B (fr)
MX (1) MX2012015292A (fr)
NZ (1) NZ604345A (fr)
PE (1) PE20130395A1 (fr)
PL (1) PL2585467T3 (fr)
PT (1) PT3012258T (fr)
RS (1) RS54761B1 (fr)
SG (2) SG10201505022WA (fr)
SI (1) SI2585467T1 (fr)
SM (1) SMT201600155B (fr)
TW (3) TWI626050B (fr)
UA (1) UA112292C2 (fr)
UY (1) UY33467A (fr)
WO (1) WO2011163518A1 (fr)
ZA (1) ZA201209549B (fr)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540867T3 (es) * 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
BR112012033117A2 (pt) 2010-06-24 2016-11-22 Gilead Sciences Inc pirazolo[1,5-a]pirimidinas como agentes antivirais
MY165585A (en) 2010-06-24 2018-04-05 Takeda Pharmaceuticals Co Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
MX355782B (es) 2010-11-03 2018-04-30 Dow Agrosciences Llc Composiciones pesticidas y procesos relacionados a las mismas.
JP2014517079A (ja) 2011-06-22 2014-07-17 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｒキナーゼ阻害剤として有用な化合物
JP5531066B2 (ja) * 2011-08-24 2014-06-25 田辺三菱製薬株式会社 ピラゾロピリミジン化合物及びｐｄｅ１０阻害剤としてのその使用
MX355431B (es) 2011-10-26 2018-04-18 Dow Agrosciences Llc Composiciones plaguicidas y procesos relacionados con dichas composiciones.
PT2794611T (pt) * 2011-12-22 2017-12-06 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas como agentes antivirais
HUE045727T2 (hu) * 2012-04-17 2021-12-28 Gilead Sciences Inc Vegyületek és eljárások vírusellenes kezeléshez
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
BR112014026746A2 (pt) 2012-04-27 2017-06-27 Dow Agrosciences Llc composições pesticidas e processos relacionados com as mesmas
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
AU2013344716B2 (en) 2012-11-16 2018-03-01 University Health Network Pyrazolopyrimidine compounds
LT3418281T (lt) 2012-12-07 2021-01-11 Vertex Pharmaceuticals Inc. Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui
PT2968297T (pt) 2013-03-15 2019-01-10 Verseon Corp Compostos aromáticos multissubstituídos como inibidores da serina protease
WO2014143242A1 (fr) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Composés utiles en tant qu'inhibiteurs de la kinase atr
JP2016512815A (ja) 2013-03-15 2016-05-09 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Ａｔｒキナーゼの阻害剤として有用な縮合ピラゾロピリミジン誘導体
EP2970289A1 (fr) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Composés utiles en tant qu'inhibiteurs de la kinase atr
WO2014175370A1 (fr) * 2013-04-25 2014-10-30 塩野義製薬株式会社 Dérivé de pyrrolidine et composition pharmaceutique en contenant
CN105636936B (zh) 2013-08-21 2022-04-05 詹森生物制药有限公司 抗病毒化合物
EP3057431A4 (fr) 2013-10-17 2017-04-05 Dow AgroSciences LLC Procédés de préparation de composés pesticides
MX2016004942A (es) 2013-10-17 2016-06-28 Dow Agrosciences Llc Procesos para la preparacion de compuestos plaguicidas.
CN105636444B (zh) 2013-10-17 2018-04-27 美国陶氏益农公司 制备杀虫化合物的方法
CA2925953C (fr) 2013-10-17 2021-11-02 Dow Agrosciences Llc Procedes de preparation de composes pesticides
KR20160074540A (ko) 2013-10-17 2016-06-28 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
KR20160074542A (ko) 2013-10-17 2016-06-28 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
KR20160074633A (ko) 2013-10-22 2016-06-28 다우 아그로사이언시즈 엘엘씨 상승작용적 살충 조성물 및 관련 방법
MX2016005326A (es) 2013-10-22 2016-08-08 Dow Agrosciences Llc Composiciones pesticidas sinergicas y metodos relacionados.
CN105828611A (zh) 2013-10-22 2016-08-03 美国陶氏益农公司 协同杀虫组合物和相关方法
CA2926444A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procedes associes
AR098101A1 (es) 2013-10-22 2016-05-04 Dow Agrosciences Llc Composiciones plaguicidas y métodos relacionados
RU2656889C2 (ru) 2013-10-22 2018-06-07 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Пестицидные композиции и соответствующие способы
NZ719749A (en) 2013-10-22 2017-10-27 Dow Agrosciences Llc Pesticidal compositions and related methods
AU2014340407B2 (en) 2013-10-22 2017-05-04 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
WO2015061149A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procédés associés
AR098092A1 (es) 2013-10-22 2016-05-04 Dow Agrosciences Llc Composiciones plaguicidas sinérgicas y los métodos relacionados
KR102286233B1 (ko) 2013-10-22 2021-08-06 코르테바 애그리사이언스 엘엘씨 살충 조성물 및 관련 방법
RU2016119576A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и связанные с ними способы
MX2016005305A (es) 2013-10-22 2017-03-01 Dow Agrosciences Llc Composiciones pesticidas sinergicas y metodos relacionados.
WO2015061145A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procédés associés
KR20160074635A (ko) 2013-10-22 2016-06-28 다우 아그로사이언시즈 엘엘씨 상승작용적 살충 조성물 및 관련 방법
US9801376B2 (en) 2013-10-22 2017-10-31 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
EP3071036A4 (fr) 2013-10-22 2017-08-23 Dow AgroSciences LLC Compositions pesticides et procédés associés
PT3077397T (pt) 2013-12-06 2020-01-22 Vertex Pharma Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo
RS60013B1 (sr) 2014-06-05 2020-04-30 Vertex Pharma Radioaktivno obeleženi derivati jedinjenja 2-amino-6-fluoro-n-[5-fluoropiridin-3-il]pirazolo[1,5-a]pirimidin-3-karboksamida, korisnog kao inhibitora atr kinaze, dobijanje pomenutog jedinjenja i njegovi različiti čvrsti oblici
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
CA2950780C (fr) 2014-06-17 2023-05-16 Vertex Pharmaceuticals Incorporated Methode de traitement anticancereux utilisant une association d'inhibiteurs de chk1 et d'atr
MA40403A (fr) * 2014-07-22 2017-05-31 Alios Biopharma Inc Méthodes de traitement de paramyxovirus
CA2954631A1 (fr) 2014-07-31 2016-02-04 Dow Agrosciences Llc Procede pour la preparation de 3-(3-chloro-1h-pyrazol-1-yl)pyridine
EP3174856A4 (fr) 2014-07-31 2018-01-10 Dow AgroSciences LLC Procédé pour la préparation de 3-(3-chloro-1h-pyrazol-1-yl) pyridine
US9029556B1 (en) 2014-07-31 2015-05-12 Dow Argosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
SG11201700851WA (en) * 2014-08-05 2017-03-30 Alios Biopharma Inc Combination therapy for treating a paramyxovirus
WO2016028328A1 (fr) 2014-08-19 2016-02-25 Dow Agrosciences Llc Procédé de préparation de 3-(3-chloro-1h-pyrazol-1-yl)pyridine
KR20170058388A (ko) 2014-09-12 2017-05-26 다우 아그로사이언시즈 엘엘씨 3-(3-클로로-1h-피라졸-1-일)피리딘의 제조 방법
WO2016044662A1 (fr) 2014-09-17 2016-03-24 Verseon Corporation Composés de pyridone substituée par pyrazolyl en tant qu'inhibiteurs de sérine protéase
EA030636B1 (ru) * 2014-12-08 2018-09-28 Янссен Сайенсиз Айрлэнд Юси Замещенные пиперидином трициклические производные пиразоло[1,5-a]пиримидина с ингибирующей активностью в отношении репликации респираторно-синцитиального вируса (rsv)
US9981976B2 (en) * 2014-12-08 2018-05-29 Janssen Sciences Ireland Uc Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)
RS62434B1 (sr) 2014-12-26 2021-11-30 Univ Emory Antivirusni n4-hidroksicitidin derivati
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
ES2931460T3 (es) * 2015-02-27 2022-12-29 Verseon Int Corporation Compuestos de pirazol sustituido como inhibidores de serina proteasa
JP2018076234A (ja) * 2015-03-16 2018-05-17 大正製薬株式会社 ピラゾロ［１，５−ａ］ピリミジン化合物
JO3637B1 (ar) * 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
AU2016331955B2 (en) 2015-09-30 2022-07-21 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
WO2017197036A1 (fr) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Dégronimères spirocycliques pour la dégradation de protéines cibles
EP3454856B1 (fr) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Dégronimères hétérocycliques pour la dégradation de protéines cibles
EP3455218A4 (fr) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. Dégronimères de type glutarimide liés au carbone c3 pour la dégradation de protéines cibles
WO2018045071A1 (fr) 2016-08-31 2018-03-08 Agios Pharmaceuticals, Inc. Inhibiteurs de processus métaboliques cellulaires
WO2018125817A1 (fr) 2016-12-29 2018-07-05 Dow Agrosciences Llc Procédés de préparation de composés pesticides
CN110139853B (zh) 2016-12-29 2023-06-16 美国陶氏益农公司 用于制备杀有害生物化合物的方法
WO2019067864A1 (fr) 2017-09-29 2019-04-04 Enanta Pharmaceuticals, Inc. Agents pharmaceutiques en combinaison en tant qu'inhibiteurs de rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
CN111372592A (zh) 2017-12-07 2020-07-03 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途
EA202091835A1 (ru) 2018-01-31 2020-10-20 Янссен Сайенсиз Айрлэнд Анлимитед Компани Замещенные циклоалкилом пиразолопиримидины, обладающие активностью против rsv
ES2957316T3 (es) * 2018-04-23 2024-01-17 Janssen Sciences Ireland Unlimited Co Compuestos heteroaromáticos que tienen actividad contra VSR
JP7520816B2 (ja) 2018-09-06 2024-07-23 シダラ セラピューティクス インコーポレーテッド ウイルス感染症の治療のための組成物及び方法
CN112996790B (zh) 2018-10-30 2023-11-03 克洛诺斯生物公司 用于调节cdk9活性的化合物、组合物和方法
EP3903788A4 (fr) * 2018-12-27 2022-09-07 Taisho Pharmaceutical Co., Ltd. Composé macrocyclique de pyrazolo[1,5-a] pyrimidine
EP4028392A1 (fr) * 2019-09-09 2022-07-20 Cidara Therapeutics, Inc. Compositions et méthodes pour le traitement du virus respiratoire syncytial
CN116425754A (zh) * 2021-12-30 2023-07-14 苏州爱科百发生物医药技术有限公司 芳杂双环化合物及其抗病毒用途

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
FR2224175B1 (fr) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US4955371A (en) 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
DE69233690T2 (de) 1991-07-02 2008-01-24 Nektar Therapeutics, San Carlos Abgabevorrichtung für nebelförmige Medikamente
US5261538A (en) 1992-04-21 1993-11-16 Glaxo Inc. Aerosol testing method
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5543413A (en) * 1994-02-25 1996-08-06 Regents Of The University Of Michigan Heterocyclic thioamides and related analogs as antiviral agents with a unique mode of action
US6342501B1 (en) * 1994-02-25 2002-01-29 The Regents Of The University Of Michigan Pyrrolo[2,3-d] pyrimidines as antiviral agents
WO1996000730A1 (fr) 1994-06-29 1996-01-11 Smithkline Beecham Corporation Antagonistes du recepteur de la vitronectine
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5544647A (en) 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
EA200000840A1 (ru) * 1998-02-17 2001-02-26 Туларик, Инк. Антивирусные производные пиримидина
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
CA2478715A1 (fr) 2002-03-13 2003-09-25 Pharmacia & Upjohn Company Nouveaux derives de pyrazolo(1,5-a)pyridine utilises en tant que modulateurs du neurotransmetteur
WO2003095455A2 (fr) * 2002-05-10 2003-11-20 Smithkline Beecham Corporation Composes therapeutiques
CA2487211C (fr) 2002-06-04 2010-09-14 Neogenesis Pharmaceuticals, Inc. Composes de pyrazolo(1,5a)pyrimidine servant d'agents antiviraux
DE10247271A1 (de) 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
WO2005061513A1 (fr) * 2003-12-24 2005-07-07 Biota Scientific Management Pty Ltd Agents polycycliques pour le traitement d'infections par le virus syncytial respiratoire
SG133452A1 (en) 2005-12-30 2007-07-30 Novartis Ag Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases
WO2008070447A2 (fr) 2006-11-21 2008-06-12 Smithkline Beecham Corporation Composés anti-viraux
JP2011506484A (ja) 2007-12-13 2011-03-03 アルニラム ファーマシューティカルズ， インコーポレイテッド Ｒｓｖ感染の予防または治療のための方法および組成物
WO2009079011A1 (fr) 2007-12-19 2009-06-25 The Scripps Research Institute Benzimidazoles et analogues comme inhibiteurs de la rho-kinase
AU2009218515A1 (en) 2008-02-26 2009-09-03 Novartis Ag Heterocyclic compounds as inhibitors of CXCR2
TW201000107A (en) 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
US20110275673A1 (en) 2008-09-19 2011-11-10 Yibin Xiang Inhibitors of sphingosine kinase 1
EP2182081B1 (fr) 2008-10-29 2014-01-22 Neue Materialien Bayreuth GmbH Procédé destiné au traitement thermique d'un corps en tôle d'acier revêtu
PT2373172E (pt) 2008-12-03 2013-10-21 Presidio Pharmaceuticals Inc Inibidores de ns5a de hcv
CA2746943A1 (fr) 2008-12-18 2010-07-15 Boehringer Ingelheim International Gmbh Inhibiteurs du recepteur 5-ht2b de la serotonine
WO2010075376A2 (fr) 2008-12-23 2010-07-01 Abbott Laboratories Composés antiviraux
TWI438200B (zh) 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
WO2010099527A1 (fr) 2009-02-27 2010-09-02 Enanta Pharmaceuticals, Inc. Inhibiteurs du virus de l'hépatite c
WO2010101246A1 (fr) 2009-03-05 2010-09-10 塩野義製薬株式会社 Dérivés de la pipéridine et de la pyrrolidine dotés d'un antagonisme pour les récepteurs npy y5
DK2455376T3 (en) 2009-06-11 2015-03-02 Abbvie Bahamas Ltd Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
WO2010148006A1 (fr) 2009-06-16 2010-12-23 Enanta Pharmaceuticals, Inc. Inhibiteurs du virus de l'hépatite c
US8221737B2 (en) 2009-06-16 2012-07-17 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
US8623899B2 (en) 2009-08-07 2014-01-07 Janssen Research & Development Ireland Bis-benzimidazole derivatives as hepatitis C virus inhibitors
US20110274648A1 (en) 2009-11-11 2011-11-10 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
WO2011099832A2 (fr) 2010-02-12 2011-08-18 Crystalgenomics, Inc. Nouveau composé de benzimidazole, son procédé de préparation et composition pharmaceutique le contenant
CA2800509A1 (fr) 2010-05-24 2011-12-01 Presidio Pharmaceuticals, Inc. Inhibiteurs de ns5a du vhc
BR112012033117A2 (pt) * 2010-06-24 2016-11-22 Gilead Sciences Inc pirazolo[1,5-a]pirimidinas como agentes antivirais
US20120027752A1 (en) 2010-07-22 2012-02-02 Gilead Sciences, Inc. Methods and compounds for treating paramyxoviridae virus infections
PT2794611T (pt) 2011-12-22 2017-12-06 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas como agentes antivirais
HUE045727T2 (hu) 2012-04-17 2021-12-28 Gilead Sciences Inc Vegyületek és eljárások vírusellenes kezeléshez

Also Published As

Publication number Publication date
HK1221715A1 (zh) 2017-06-09
JP2013534524A (ja) 2013-09-05
HUE029174T2 (hu) 2017-02-28
US8809330B2 (en) 2014-08-19
ZA201209549B (en) 2015-07-29
AU2011270798B2 (en) 2015-03-19
TWI476201B (zh) 2015-03-11
HK1223934A1 (zh) 2017-08-11
WO2011163518A1 (fr) 2011-12-29
ES2700542T3 (es) 2019-02-18
CY1118239T1 (el) 2017-06-28
HRP20160431T1 (hr) 2016-05-20
IL257410A (en) 2018-04-30
TW201639576A (zh) 2016-11-16
KR101970837B1 (ko) 2019-04-19
ES2571334T3 (es) 2016-05-24
SMT201600155B (it) 2016-07-01
MX2012015292A (es) 2013-05-30
IL223253B (en) 2018-02-28
JP2020059750A (ja) 2020-04-16
KR20140032333A (ko) 2014-03-14
JP6684552B2 (ja) 2020-04-22
UY33467A (es) 2012-01-31
EA201591390A1 (ru) 2016-06-30
TW201213332A (en) 2012-04-01
DK2585467T3 (en) 2016-06-13
CA2800834A1 (fr) 2011-12-29
CO6640297A2 (es) 2013-03-22
EA201291172A1 (ru) 2013-05-30
EP2585467A1 (fr) 2013-05-01
TWI537272B (zh) 2016-06-11
AP2013006686A0 (en) 2013-01-31
US20170190708A1 (en) 2017-07-06
AR082275A1 (es) 2012-11-28
NZ604345A (en) 2015-02-27
US20180298011A1 (en) 2018-10-18
EP2585467B1 (fr) 2016-03-02
JP5878171B2 (ja) 2016-03-08
TW201529578A (zh) 2015-08-01
HK1184157A1 (zh) 2014-01-17
US20140072554A1 (en) 2014-03-13
CA2800834C (fr) 2018-10-23
US9238039B2 (en) 2016-01-19
CL2012003632A1 (es) 2013-11-04
PT3012258T (pt) 2018-12-14
ME02397B (fr) 2016-09-20
CN105481866A (zh) 2016-04-13
US20120003215A1 (en) 2012-01-05
BR112012033117A2 (pt) 2016-11-22
CR20130023A (es) 2013-03-25
TWI626050B (zh) 2018-06-11
EA023223B1 (ru) 2016-05-31
AU2011270798A1 (en) 2013-01-24
JP2017019850A (ja) 2017-01-26
US20170362244A1 (en) 2017-12-21
PE20130395A1 (es) 2013-04-10
ECSP13012400A (es) 2013-03-28
EP3012258A1 (fr) 2016-04-27
PL2585467T3 (pl) 2016-09-30
SI2585467T1 (sl) 2016-04-29
SG186291A1 (en) 2013-02-28
RS54761B1 (sr) 2016-10-31
AP3417A (en) 2015-09-30
US20140154240A1 (en) 2014-06-05
US8486938B2 (en) 2013-07-16
EP3012258B1 (fr) 2018-09-19
SG10201505022WA (en) 2015-07-30
IL223253A0 (en) 2013-02-03
US20160130275A1 (en) 2016-05-12
UA112292C2 (uk) 2016-08-25
CN102958933A (zh) 2013-03-06
CN102958933B (zh) 2016-02-03
US9957275B2 (en) 2018-05-01
ECSP17084267A (es) 2018-01-31
JP2015218176A (ja) 2015-12-07

Similar Documents

Publication Publication Date Title
MA34392B1 (fr) Pyrimidines en tant qu'agents antiviraux
MA37942A2 (fr) Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
MA37712A2 (fr) Inhibiteurs macrocycliques de virus flaviviridae
MA41134B1 (fr) Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales
IN2014CN00562A (fr)
MA35750B1 (fr) Dérivés de nucléoside substitué 2',4'-difluoro-2'-méthyle en tant qu'inhibiteurs de la réplication de l'arn du vhc (virus de l'hépatite c)
MA34470B1 (fr) Procédés et composés pour traiter des infections à virus paramyxoviridae
EA201391495A1 (ru) Производные пиримидина для лечения вирусных инфекций
MA37400B1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
PH12015501678A1 (en) Inhibitors of influenza viruses replication
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
CR20130560A (es) Compuestos de bezotiazol y su uso farmacéutico
EA201001508A1 (ru) Мостиковые гетероциклические соединения в качестве ингибиторов интегразы вич
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
EA201070988A1 (ru) Противовирусные терапевтические средства
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
EA200971096A1 (ru) Терапевтические композиции и их применение
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
EA201270492A1 (ru) Соединения для лечения дислипидемии и связанных с ней заболеваний
MA38315B1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
MA35895B1 (fr) Inhibiteurs d'iap
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства